The association of the cribriform pattern with outcome for prostatic adenocarcinomas

Pathology Research and Practice

Volumn 210, Issue 10, 2014, Pages 640-644

  Kir, G ^a   Sarbay, B C ^a   Gumus E ^a   Topal, C S ^a  

^a Umraniye Education and Research Hospital   (Turkey)

Author keywords

Cribriform pattern; Gleason pattern; Gleason score; Prostate gland; Prostatic adenocarcinoma

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE-SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMICAL PROSTATE SPECIFIC ANTIGEN RECURRENCE; CANCER PROGNOSIS; CANCER STAGING; CRIBRIFORM PATTERN; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALE GENITAL TRACT PARAMETERS; ONCOLOGICAL PARAMETERS; PROSTATE ADENOCARCINOMA; ADENOCARCINOMA; HUMANS; METABOLISM; METHODS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

ADENOCARCINOMA; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84908074991     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.06.002     Document Type: Article

References (20)

1. Amin M., Boccon-Gibod L., Egevad L., et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand. J. Urol. Nephrol. 2005, (Suppl. 216):20-33.
2. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother. Rep. 1966, 50:125-138.
3. Gleason D.F., Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 1974, 111:58-64.
4. Qian J., Jenkins R.B., Bostwick D.G. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepitelial neoplasia and carcinoma by fluorescence in situ hybridization. Mod. Pathol. 1997, 10:1113-1119.
5. Epstein J.I., Allsbrook W.C., Amin M.B., Egevad L.L. ISUP grading committee: the 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 2005, 29:1228-1242.
6. Egevad L., Granfors T., Karlberg L., Bergh A., Stattin P. Prognostic value of the Gleason score in prostate cancer. BJU Int. 2002, 89:538-542.
7. Epstein J.I. An update of the Gleason grading system. J. Urol. 2010, 183:433-440.
8. Lotan T.L., Epstein J.I. Clinical implications of changing definitions within the Gleason grading system. Nat. Rev. Urol. 2010, 7:136-142.
9. Qian J., Wollan P., Bostwick D.G. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum. Pathol. 1997, 28:143-148.
10. Magi-Galluzzi C., Evans A.J., Delahunt B., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod. Pathol. 2011, 24:26-38.
11. Berney D.M., Wheeler T.M., Grignon D.J., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod. Pathol. 2011, 24:39-47.
12. Tan P.H., Cheng L., Srigley J.R., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod. Pathol. 2011, 24:48-57.
13. Martinez-Rodriguez M., Ramos D., Mayordomo E., Soriano P., Llombart-Bosch A. Analysis of cribriform Gleason grade 3 in prostatic carcinoma. A histopathological and immunohistochemical study of 32 cases. Histopathology 2007, 51:717-719.
14. Latour M., Amin M.B., Billis A., et al. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am. J. Surg. Pathol. 2008, 32:1532-1539.
15. Iczkowski K.A., Torkko K.C., Kotnis G.R., et al. Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome. Am. J. Clin. Pathol. 2011, 136:98-107.
16. Brimo F., Montironi R., Egevad L., et al. Contemporary grading for prostate cancer: implications for patient care. Eur. Urol. 2013, 63:892-901.
17. Kryvenko O.N., Gupta N.S., Virani N., et al. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens. Arch. Pathol. Lab. Med. 2013, 137:610-617.
18. Ross H.M., Kryvenko O.N., Cowan J.E., Simko J.P., Wheeler T.M., Epstein J.I. Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?. Am. J. Surg. Pathol. 2012, 36:1346-1352.
19. Dong F., Yang P., Wang C., Wu S., Xiao Y., McDougal W.S., et al. Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am. J. Surg. Pathol. 2013, 37:1855-1861.
20. Dong F., Wang C., Farris B., Wu S., Lee H., Olumi A.F., et al. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am. J. Surg. Pathol. 2012, 36:838-843.